Pertuzumab is a man-made antibody developed using molecular cloning and recombinant DNA technology. Pertuzumab is thought to block the HER2 receptors when there is overexpression, thereby blocking growth of the cancer.
Augmentin is the brand name of a combination antibiotic drug containing amoxicillin and clavulanate potassium. It's used to treat bacterial infections in your airways, such as a sinus infection or pneumonia. It's also available in an extra-strength formulation (Augmentin ES), an extended-release formula (Augmentin XR), and under the brand name Amoclan.
AUGMENTIN is an oral antibacterial combination consisting of the semisynthetic antibiotic amoxicillin and the Î²-lactamase inhibitor, clavulanate potassium (the potassium salt of clavulanic acid). Amoxicillin is an analog of ampicillin, derived from the basic penicillin nucleus, 6-aminopenicillanic acid.